Page last updated: 2024-08-24

duloxetine hydrochloride and Behavior Disorders

duloxetine hydrochloride has been researched along with Behavior Disorders in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aftab, A; Latorre, S1
Fuller, RR; Hughes, S; Lacasse, J; Spaulding-Givens, J1
Cunningham, EA; Kassam, AS; Musco, SE1
Corrigan, PW; Fokuo, JK; Kosyluk, KA; Park, JH1
Guski, LS; Gøtzsche, PC; Maund, E1
Kranzler, J; Nemeroff, CB; Owens, MJ; Plott, SJ; Rao, SG; Vaishnavi, SN1
Borges-Gonzalez, S; Flockhart, D; Preskorn, SH1
Aubry, JM; Barbe, R; Bertschy, G; Bryois, C; Delini-Stula, A; Gervasoni, N; Merlo, M1

Reviews

3 review(s) available for duloxetine hydrochloride and Behavior Disorders

ArticleYear
Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2017, Feb-06, Volume: 189, Issue:5

    Topics: Affective Symptoms; Akathisia, Drug-Induced; Antidepressive Agents; Anxiety; Duloxetine Hydrochloride; Female; Humans; Mental Disorders; Psychoses, Substance-Induced; Randomized Controlled Trials as Topic; Risk Assessment; Sleep Initiation and Maintenance Disorders; Suicidal Ideation; Treatment Outcome; Urinary Incontinence, Stress; Violence

2017
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.
    Journal of psychiatric practice, 2006, Volume: 12, Issue:5

    Topics: Anti-HIV Agents; Antidepressive Agents; Antiparkinson Agents; Apomorphine; Atazanavir Sulfate; Azabicyclo Compounds; Carbamates; Central Nervous System Agents; Cytochrome P-450 Enzyme System; Drug Approval; Drug Interactions; Duloxetine Hydrochloride; Furans; Humans; Hypnotics and Sedatives; Indenes; Long QT Syndrome; Mental Disorders; Oligopeptides; Organophosphates; Piperazines; Psychopharmacology; Pyridines; Sulfonamides; Thiophenes

2006
[Psychiatry].
    Revue medicale suisse, 2007, Jan-17, Volume: 3, Issue:94

    Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Child; Depression; Duloxetine Hydrochloride; Humans; Mental Disorders; Schizophrenia; Thiophenes

2007

Trials

1 trial(s) available for duloxetine hydrochloride and Behavior Disorders

ArticleYear
How does direct to consumer advertising affect the stigma of mental illness?
    Community mental health journal, 2014, Volume: 50, Issue:7

    Topics: Adult; Advertising; Attitude to Health; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Mental Disorders; Psychotropic Drugs; Stereotyping; Surveys and Questionnaires; Thiophenes

2014

Other Studies

4 other study(ies) available for duloxetine hydrochloride and Behavior Disorders

ArticleYear
Geriatric-Onset Olfactory Reference Syndrome Successfully Treated with Duloxetine and Memantine.
    The primary care companion for CNS disorders, 2017, Mar-23, Volume: 19, Issue:2

    Topics: Age of Onset; Aged; Comorbidity; Duloxetine Hydrochloride; Female; Humans; Memantine; Mental Disorders; Olfactory Perception; Perceptual Disorders; Psychotropic Drugs; Syndrome

2017
Adverse effects and treatment satisfaction among online users of four antidepressants.
    Psychiatry research, 2017, Volume: 255

    Topics: Affective Symptoms; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Humans; Internet; Mental Disorders; Patient Satisfaction; Piperazines; Sulfides; Vilazodone Hydrochloride; Vortioxetine

2017
Dangers of Rapid Dosing: A Case of Dose-Dependent Drug-Induced Liver Injury From Duloxetine.
    The primary care companion for CNS disorders, 2019, Mar-21, Volume: 21, Issue:2

    Topics: Adult; Antidepressive Agents; Chemical and Drug Induced Liver Injury; Diagnosis, Differential; Disease Progression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Female; Humans; Mental Disorders

2019
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Biological psychiatry, 2004, Feb-01, Volume: 55, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Citalopram; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Milnacipran; Nerve Tissue Proteins; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Venlafaxine Hydrochloride

2004